Skip to main content
Log in

Vanadium increases GLUT4 in diabetic rat skeletal muscle

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The effect of vanadium in lowering blood glucose in diabetic animals is well established; however, the exact mechanism of action of vanadium still eludes us. There are several reports from in vitro studies indicating that vanadium increases enzyme activity in insulin signalling pathways, however these findings have not been duplicated in vivo. Glucose transporters (GLUT) have a major role to play in any glucoregulatory effects. Insulin dependent GLUT4 is a major glucose transporter present in skeletal muscle, adipocytes and heart. In the present study we found that the plasma glucose in streptozotocin (STZ) diabetic animals was restored to normal following treatment with a single dose of BMOV, an organic vanadium compound, given by oral gavage (0.6 mmol/kg), similar to the response with chronic BMOV treatment. The response to BMOV by oral gavage was rapid and the animals were normoglycemic within 24 h of treatment and still demonstrated a significant effect even after 72 h. Using a specific antibody against GLUT4 we found an overall reduction in the GLUT4 in the total membrane fraction in skeletal muscle of diabetic animals. However, with a single dose of BMOV the GLUT4 level was restored to normal. This is the first report that establishes a direct effect of vanadium on the regulation of GLUT4 expression in diabetic animals in vivo, and may at least partially explain the glucoregulatory effects of vanadium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kahn BB: Type 2 Diabetes: When insulin secretion fails to compensate for insulin resistance. Cell 92: 593–596, 1998

    Google Scholar 

  2. Avruch J: Insulin signal transduction through protein kinase cascades. Mol Cell Biochem 182: 31–48, 1998

    Google Scholar 

  3. Katz EB, Burcelin R, Tsao TS, Stenbit AE, Charron MJ: The metabolic consequences of altered glucose transporter expression in transgenic mice. J Mol Med 74: 563–652, 1996

    Google Scholar 

  4. Czech MP, Corvera S: Signalling mechanisms that regulate glucose transport. J Biol Chem 274: 1865–1868, 1999

    Google Scholar 

  5. Pessin JE, Thurmond DC, Elmendorf JS, Coler KJ, Okada S: Molecular basis of insulin stimulated GLUT4 vesicle trafficking. J Biol Chem 274: 2593–2596, 1999

    Google Scholar 

  6. Krook A, Bjornholm M, Galuska D, Jiang XJ, Fahlman R, Myers MG Jr, Wallberg-Henriksson H, Zierath JR: Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetes patients. Diabetes 49: 284–292, 2000

    Google Scholar 

  7. McDowell HE, Walker T, Hajduch E, Christie G, Batty IH, Downes CP, Jundal HS: Inositol phospholipid-3 kinase is activated by cellular stress but is not required for the stress induced activation of glucose transport in L6 rat skeletal muscle cells. Eur J Biochem 247: 306–313, 1997

    Google Scholar 

  8. Zierath JR, Houseknecht KL, Gnudi L, Kahn BB: High fat feeding impairs insulin stimulated GLUT4 recruitment via an early insulin signalling defect. Diabetes 46: 215–223, 1997

    Google Scholar 

  9. Niklasson M, Homang A, Sjorstrand M, Strindberg L, Lonnorth P: Muscle glucose uptake is effectively activated by ischemia in type 2 diabetic subjects. Diabetes 49: 1178–1185, 2000

    Google Scholar 

  10. Stevenson RW, Kreutter DK, Andrews KM, Genereux PE, Gibbs EM: Possibility of distinct insulin signalling pathways beyond phosphatidylinositol 3-kinase mediating glucose transport and lipogenesis. Diabetes 47: 179–185, 1998

    Google Scholar 

  11. Zisman A, Peroni OD, Abel D, Michael MD, Mauvais-Jarvis R, Lowell BB, Wojtaszewski JFP, Hirshman MF, Virkamaki A, Goodyear LJ, Kahn CR, Kahn BB: Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nature Med 6: 924–928, 2000

    Google Scholar 

  12. Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest 106: 171–176, 2000

    Google Scholar 

  13. Charron MJ, Karz EB, Olson AL: GLUT4 gene regulation and manipulation. J Biol Chem 274: 3253–3256, 1999

    Google Scholar 

  14. Shintani M, Nishimura H, Yonemitsu S, Ogawa Y, Hayashi T, Hosoda K, Inoue G, Nakao K: Triglitazone not only increases GLUT4 but also induces its translocation in rat adipocytes. Diabetes 50: 2296–2300, 2001

    Google Scholar 

  15. Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474–1477, 1985

    Google Scholar 

  16. Tsiani E, Bogdonavic E, Sorisky A, Nagy L, Fantus IG: Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C. Diabetes 47: 1676–1686, 1998

    Google Scholar 

  17. Poucheret P, Verma S, Grynpas MD, McNeill JH: Vanadium and diabetes. Mol Cell Biochem 188: 73–80, 1998

    Google Scholar 

  18. Mohammad A, Bhanot S, McNeill JH: In vivo effects of vanadium in diabetic rats are independent of changes in PI-3 kinase activity in skeletal muscle. Mol Cell Biochem 223: 103–108, 2001

    Google Scholar 

  19. Zhou M, Sevilla L, Vallega G, Chen P, Palacin M, Zorzano A, Pilch PF, Kandror KV: Insulin dependent protein trafficking in skeletal muscle cells. Am J Physiol 275: E187–E196, 1998

    Google Scholar 

  20. Kim Y-B, Inoue T, Nakajima R, Morishita YS, Tokuyama K, Suzuki M: Effect of long-term exercise on gene expression on insulin signalling pathway intermediates in skeletal muscle. Biochem Biophys Res Commun 254: 721–727, 1999

    Google Scholar 

  21. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel P, Pessin JE, Salteil AR: CAP defines a second signalling pathway required for insulin stimulated glucose transport. Nature 407: 202–207, 2000

    Google Scholar 

  22. Marzban L, Bhanot S, McNeill JH: In vivo effects of bis(maltolato)-oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats. Mol Cell Biol 223: 147–157, 2001

    Google Scholar 

  23. Semiz S, Orvig C, McNeill JH: Effects of diabetes vanadium and insulin on glycogen synthase activation in Wistar rats. Mol Cell Biochem (in press), 2002

  24. Cam MC, Brownsey RW, Rodrigues B, McNeill JH: Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats. Metabolism 50: 674–680, 2001

    Google Scholar 

  25. Li SH, McNeill JH: In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats. Mol Cell Biochem 217: 121–129, 2001

    Google Scholar 

  26. Richardson JM, Balon TW, Treadway JL, Pessin JE: Differential regulation of glucose transporter activity and expression in red and white skeletal muscle. J Biol Chem 266: 12690–12694, 1991

    Google Scholar 

  27. Kahn BB, Pederson O: Suppression of GLUT4 in skeletal muscle of rats that are obese from high fat feeding but not from high carbohydrate feeding or genetic obesity. Endocrinology 132: 13–22, 1993

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohammad, A., Sharma, V. & McNeill, J.H. Vanadium increases GLUT4 in diabetic rat skeletal muscle. Mol Cell Biochem 233, 139–143 (2002). https://doi.org/10.1023/A:1015558328757

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015558328757

Navigation